about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex has numerous clinical oncology studies underway or in the planning stage.

Clinical Trials >>

News/Events

Kinex Pharmaceuticals Appoints Mr. Michael Murphy to the Board of Directors Tuesday, July 1st, 2014

Kinex Pharmaceuticals announced today that Dr. Jean-Pierre Sommadossi has elected to step down from the Board of Directors of Kinex but will continue to

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Report Encouraging Results on Oraxol® for Patients with Advanced Gastric Cancer from a Phase I/II Clinical Study Monday, June 30th, 2014

Hanmi Pharmaceuticals announces a positive study on Oraxol® use in a Phase I/II clinical proof-of-concept study (Study HM-OXL-201) of Oraxol – an

News/Events >>